An adverse drug response (ADR) is a negative or damaging reaction that occurs after taking a medication or medication combination under everyday circumstances and is thought to be caused by the medication. Usually, an ADR calls for stopping the medication or lowering the dose. An adverse reaction is any injury that happens to a patient while they are taking medication, regardless of whether the medication is thought to be the cause or not. Any impact medicine has that is not the intended therapeutic effect—whether positive, negative, or neutral—is considered a side-effect. Although the terms "side-effect" and "ADR" are sometimes used interchangeably, the former generally denotes a less negative, predictable impact that may not even necessitate stopping therapy (e.g., ankle edema with vasodilators.) When a medicine's dosage or plasma concentration exceeds the therapeutic range, whether purposefully or inadvertently, it can lead to undesirable consequences. These unfavourable effects are referred to as drug toxicity (drug overdose). Addiction or dependency, major physiological harm (such as damage to the kidneys, liver, or heart), psychological impairment (abnormal behaviour patterns, hallucinations, memory loss), or even death can result from the misuse of recreational or therapeutic substances.
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami School of Medicine, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Tailored cellular environments to enable drug design
Lan Wang, Paretor LLC, United States
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : A NAMs-compatible mechanopharmacological model of drug penetration in the urinary bladder
Kunal Sharma, Swisss Federal Institute of Technology Lausanne, Switzerland
Title : Application of quality by design for pulmonary liposomes: Preliminary study to nano in-microparticle
Lucas Amaral Machado, University of Sao Paulo State – UNESP, Brazil
Title : Integrated Raman, SERS and computational approaches for the study of bioactive molecules in pharmaceutical chemistry
Maria Cristina Gamberini, University of Modena and Reggio Emilia, Italy
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, University of Alberta, Canada